"Ethereum has Hyperliquid" is easily the most retarded thing I have read in my 29 years as a homo sapien, maybe everHL is its own chainSo what does Solana have?Drift, Jupiter, and Raydium are the obvious onesAdrena, Flash, and Ranger are also relatively newBullet and Bulk are launching soonPacifica is the same thing as Aster, but settles on Solana and better UX (though note the CLOB is off-chain), it's invite-only, but I have an invite-code if you wanna try it out next tweetHyperliquid is very good (and I u ...

Core Insights - Cloudflare announced that information in its customer support system should be considered compromised due to a breach involving Salesloft's Drift application [2][4] - The breach allowed unauthorized access to Cloudflare's Salesforce instance used for customer support and case management [2][5] - Cloudflare identified and rotated 104 compromised API tokens and notified affected customers, emphasizing that its own services and infrastructure were not compromised [5][6] Data Compromise Details - The compromised data primarily includes customer contact information and basic support case data, with some interactions potentially revealing sensitive information such as access tokens [3][4] - Cloudflare urged customers to rotate any credentials shared through its support system due to the breach [4] Vendor Security Issues - Salesloft detected a security issue in its Drift application, which led to the breach, and subsequently revoked connections between Drift and Salesforce [5][6] - The breach occurred between August 8 and August 18, with Salesloft notifying all impacted customers [6] - The incident highlights the risks associated with relying on third-party vendors, which can increase a company's cybersecurity vulnerabilities [7]

Core Points - Aurora Cannabis Inc. held its Annual General and Special Meeting of Shareholders on August 8, 2025, with 17,736,521 common shares represented, accounting for 31.53% of the total issued shares [1] - The election results for the Board of Directors showed that all nominees, except for Theresa Firestone, were elected [2] - Following the meeting, Theresa Firestone resigned from the Board effective August 31, 2025, and Michael Singer was appointed as the new Lead Independent Director and Chair of the Human Resources and Compensation Committee [3][4] - Shareholders approved the appointment of Ernst & Young LLP as auditors and amendments to the Company's RSU Plan, PSU Plan, and Share Option Plan, but the advisory vote on executive compensation did not pass [5] Voting Results - Miguel Martin received 5,513,929 votes for his position, while Theresa Firestone received only 2,620,830 votes for her position, leading to her resignation [2][3] - The voting results indicate a strong preference for the other board nominees, with the highest votes for Michael Singer at 5,194,307 [2] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across multiple regions including Canada, Europe, Australia, and New Zealand [7] - The company offers a diverse portfolio of brands in both adult-use and medical cannabis markets, emphasizing high-quality products and innovation [7][8]

Core Viewpoint - Aurora Cannabis Inc. is set to discuss its strategic direction, recent milestones, and growth opportunities at the Canaccord Genuity 45th Annual Growth Conference, emphasizing its commitment to innovation and leadership in the global medical cannabis sector [2][6]. Group 1: Company Overview - Aurora Cannabis Inc. is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4]. - The company offers a diverse portfolio of brands, including adult-use brands such as Drift and San Rafael '71, and medical cannabis brands like MedReleaf and CanniMed [4]. - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [4]. Group 2: Conference Details - The conference call is scheduled for August 13th at 1:30 PM Eastern Standard Time, with a live audio webcast available for registration [3]. - Simona King, the Chief Financial Officer, will participate in a fireside chat and conduct one-on-one meetings with investors throughout the day [1][3]. Group 3: Strategic Focus - The discussion at the conference will highlight Aurora's strategic direction and its commitment to innovation within the medical cannabis industry [2]. - The company aims to leverage recent milestones to identify and pursue growth opportunities in the evolving cannabis market [2].

Core Viewpoint - Aurora Cannabis Inc. is holding its annual general and special meeting on August 8, 2025, and shareholders are encouraged to vote in advance of the proxy voting deadline on August 6, 2025 [1][2][3] Company Information - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company offers a diverse portfolio of brands, including adult-use brands such as Drift, San Rafael '71, Daily Special, Tasty's, Being, and Greybeard, as well as medical cannabis brands like MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co [4] - Aurora also has a controlling interest in Bevo Farms Ltd., which is North America's leading supplier of propagated agricultural plants [4] - The company's common shares are traded on NASDAQ and TSX under the symbol "ACB" [5] Voting Information - Shareholders are advised to vote their shares online or by telephone, following the instructions on their proxy forms [3][4] - For assistance with voting, shareholders can contact Laurel Hill Advisory Group, the company's proxy solicitation agent [4][7]

Core Viewpoint - Aurora Cannabis Inc. is set to announce its financial results for the first quarter of 2026 on August 6, 2025, and will host a conference call to discuss these results [1][5]. Group 1: Conference Call Details - The conference call is scheduled for August 6, 2025, at 8:00 a.m. Eastern Time and 6:00 a.m. Mountain Time [2]. - Miguel Martin, Executive Chairman and CEO, along with Simona King, CFO, will lead the conference call and Q&A session [2]. Group 2: Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Edmonton, Alberta, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [3]. - The company offers a diverse portfolio of brands, including adult-use brands like Drift and San Rafael '71, and medical brands such as MedReleaf and CanniMed [3]. - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [3]. Group 3: Stock Information - Aurora's common shares are traded on NASDAQ and TSX under the symbol "ACB" [4].

Core Points - Aurora Cannabis Inc. has filed and mailed the management information circular for the upcoming annual general and special meeting of shareholders [1] - The meeting is scheduled to be held virtually on August 8, 2025, at 1:00 p.m. Eastern time [2] - Shareholders are encouraged to vote their shares by the deadline of August 6, 2025, at 1:00 p.m. Eastern time [3] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company offers a diverse portfolio of adult-use and medical cannabis brands, including Drift, San Rafael '71, MedReleaf, and others [4] - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [4] Shareholder Engagement - Shareholders can access the management information circular on the company's website and are encouraged to watch a message from the CEO and CFO reflecting on fiscal 2025 [2] - The company emphasizes the importance of shareholder participation and provides contact information for assistance with voting [3]

Core Insights - Aurora Cannabis Inc. has been recognized in the Globe & Mail's 2025 Report on Business as an honouree in the Women Lead Here list, highlighting its commitment to gender diversity at the executive level [1][3] - The company boasts that 43% of its executive leadership team consists of women, emphasizing their role in driving change within the medical cannabis industry [2][3] - Aurora established the Women Empowerment Network (WEN) in 2022 to support the advancement of women within the organization, offering learning and community engagement opportunities [2] Company Overview - Aurora Cannabis Inc. is a leading global medical cannabis company based in Edmonton, Alberta, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [4] - The company's product portfolio includes various adult-use brands such as Drift, San Rafael '71, and medical cannabis brands like MedReleaf and CanniMed, among others [4] - Aurora is also a major player in the agricultural sector with a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants [4] Market Presence - Aurora's common shares are traded on NASDAQ and TSX under the symbol "ACB," indicating its established presence in the financial markets [5]

Core Insights - Aurora Cannabis Inc. is participating as a leader in the inaugural Global Cannabis Regulatory Summit (GCRS) in Washington, D.C. on March 26-27, 2025, highlighting its role in advocating for policy reform in the cannabis industry [1][2] Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Canada, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [3] - The company offers a diverse portfolio of adult-use brands including Drift, San Rafael '71, Daily Special, Tasty's, Being, and Greybeard, as well as medical cannabis brands such as MedReleaf, CanniMed, Aurora, and Whistler Medical Marijuana Co. [3] - Aurora also holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [3] Industry Engagement - The GCRS will facilitate discussions among regulators, members of Congress, international policy experts, and cannabis industry executives to shape the future of the global cannabis industry [2][3] - Aurora's participation in panel discussions aims to enhance understanding of the distinctions between medical and adult-use cannabis, informed by international political and regulatory consensus [3]